You are not currently logged in.
Access JSTOR through your library or other institution:
If You Use a Screen ReaderThis content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Opioid and Nicotine Receptors Affect Growth Regulation of Human Lung Cancer Cell Lines
Rhoda Maneckjee and John D. Minna
Proceedings of the National Academy of Sciences of the United States of America
Vol. 87, No. 9 (May, 1990), pp. 3294-3298
Published by: National Academy of Sciences
Stable URL: http://www.jstor.org/stable/2354153
Page Count: 5
You can always find the topics here!Topics: Cell lines, Lung neoplasms, Opioid analgesics, Cell growth, Receptors, Morphine, Ligands, Agonists, Opioid receptors, Cultured cells
Were these topics helpful?See something inaccurate? Let us know!
Select the topics that are inaccurate.
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Using specific ligands, we find that lung cancer cell lines of diverse histologic types express multiple, high-affinity (Kd = 10-9-10-10M) membrane receptors for μ, delta, and κ opioid agonists and for nicotine and α-bungarotoxin. These receptors are biologically active because cAMP levels decreased in lung cancer cells after opioid and nicotine application. Nicotine at concentrations (≈ 100 nM) found in the blood of smokers had no effect on in vitro lung cancer cell growth, whereas μ, delta, and κ opioid agonists at low concentrations (1-100 nM) inhibited lung cancer growth in vitro. We also found that lung cancer cells expressed various combinations of immunoreactive opioid peptides (β-endorphin, enkephalin, or dynorphin), suggesting the participation of opioids in a negative autocrine loop or tumor-suppressing system. Due to the almost universal exposure of patients with lung cancer to nicotine, we tested whether nicotine affected the response of lung cancer cell growth to opioids and found that nicotine at concentrations of 100-200 nM partially or totally reversed opioid- induced growth inhibition in 9/14 lung cancer cell lines. These in vitro results for lung cancer cells suggest that opioids could function as part of a "tumor suppressor" system and that nicotine can function to circumvent this system in the pathogenesis of lung cancer.
Proceedings of the National Academy of Sciences of the United States of America © 1990 National Academy of Sciences